China Pharma Holdings (CPHI) Depreciation & Amortization (CF) (2010 - 2026)

China Pharma Holdings has reported Depreciation & Amortization (CF) for 17 years, with the latest figure at $980570.0 in Q1 2026.

• For the quarter ending Q1 2026, Depreciation & Amortization (CF) rose 197.76% year-over-year to $980570.0; the trailing twelve-month figure through Mar 2026 stood at $2.2 million (down 2.65% YoY), and the FY2025 full-year result was $1.5 million, down 42.57% from the prior year.
• Depreciation & Amortization (CF) for Q1 2026 stood at $980570.0, up from $497425.0 in the prior quarter.
• The five-year high for Depreciation & Amortization (CF) was $980570.0 in Q1 2026, with the low at $320863.0 in Q2 2025.
• Historically, Depreciation & Amortization (CF) has averaged $620968.1 across 5 years, with a median of $683094.0 in 2023.
• Annual changes were most pronounced in 2025 — Depreciation & Amortization (CF) slumped 56.6% — and 2026, when it surged 197.76%.
• China Pharma Holdings' Depreciation & Amortization (CF) stood at $639425.0 in 2022, then gained by 8.82% to $695835.0 in 2023, then sank by 35.61% to $448073.0 in 2024, then climbed by 11.01% to $497425.0 in 2025, then jumped by 97.13% to $980570.0 in 2026.
• The last three Depreciation & Amortization (CF) figures came in at $980570.0 (Q1 2026), $497425.0 (Q4 2025), and $356034.0 (Q3 2025), per Business Quant data.